Oncotelic Therapeutics, Inc. (OTLC) has 17 open-market insider trades by 2 insiders since 2022. Over the last six months insiders net bought $38K. The most active filer is Vuong Trieu, CEO & Chairman +1.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Vuong Trieu | CEOChairman10% Owner | — | 16 | $122K | 2026-07-01 |
| Amit B. Shah | CFO | — | 1 | $1K | 2026-06-22 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Vuong Trieu | CEO & Chairman +1 | Buy | $10K | 2026-07-01 |
| Amit B. Shah | CFO | Buy | $1K | 2026-06-22 |
| Vuong Trieu | CEO & Chairman +1 | Buy | $11K | 2026-06-22 |
| Vuong Trieu | CEO & Chairman +1 | Buy | $15K | 2026-06-15 |
| Vuong Trieu | Chairman & 10% | Buy | $2K | 2025-07-08 |
| Vuong Trieu | Chairman & 10% | Buy | $10K | 2025-01-29 |
Companies that share insiders with OTLC, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Vuong Trieu | Chairman & 10% | Buy | $9K | 2024-11-22 |
| Vuong Trieu | Chairman & 10% | Buy | $10K | 2024-08-23 |
| Vuong Trieu | Chairman & 10% | Buy | $11K | 2023-06-28 |
| Vuong Trieu | Chairman & 10% | Buy | $3K | 2023-06-16 |
| Vuong Trieu | Chairman & 10% | Buy | $12K | 2023-06-14 |
| Vuong Trieu | Chairman & 10% | Buy | $4K | 2023-05-26 |
| Vuong Trieu | Chairman & 10% | Buy | $5K | 2023-05-02 |
| Vuong Trieu | Chairman & 10% | Buy | $6K | 2022-12-06 |
| Vuong Trieu | Chairman & 10% | Buy | $6K | 2022-11-22 |